Current investments
We do not have any companies open for investments at the moment. Sign up to receive an email once something new is coming up.
Completed investments
Pharmnovo AB
PharmNovo develops a novel drug for nerve pain, where there is a high, unmet need for effective and safe treatments. The candidate PN6047 shows effective pain relief in animal models, without the negative side effects associated with existing drugs.
Capitainer AB
Capitainer offers a more convenient and cost-efficient way to take blood samples. The company’s products are designed for home sampling and deliver an exact amount of blood, which is essential to get accurate results.
NEOGAP Therapeutics AB
NEOGAP has a unique approach to train the patient’s immune system to target tumour-specific mutations, so called neoantigens to eradicate the cancer. The treatment has the potential to kill the cancer cells while leaving healthy cells untouched, which significantly reduces the risk of side effects.
Exits
Liv Diagnostics
Tumor cell proliferation causes 90% of all cancer deaths. Liv Diagnostics is developing new technology to measure the spreading capacity of tumor cells and provide predictive information on the risk of metastasis.
Read more
Raytelligence
Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company focuses on elderly care in the home.
Read more
Learning to Sleep
Learning to Sleep is a digital sleep clinic. The company offers an evidence-based treatment that uniquely combines support from a sleep coach with digital aids.
Read more